| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Hiremii is a platform that brings recruitment into the digital age. Find out more on how we are helping the recruitment industry.
Boardvantage leads the market in delivering paperless process for boards and leadership. Trusted by enterprises worldwide, including half of the Fortune 500, Boardvantage sets the bar for a mobile executive experience.
Chef, Inc. provides cloud-based infrastructure automation solutions. It offers configuration management, a solution to manage complex infrastructure; cloud management that enables users to manage and scale cloud infrastructure with no downtime or interruptions, as well as build, destroy, and rebuild servers on public or private cloud; and DevOps, a solution for collaboration between development and operations. The company also provides Enterprise Chef that automates user infrastructure that accelerates time to market, helps users to manage scale and complexity, and safeguards their systems; and professional services that include planning, training and skill development, and project-based services. Chef, Inc. was formerly known as Chef, Inc. and changed its name to Opscode, Inc. in December 2013. The company was founded in 2008 and is based in Seattle, Washington.